Abstract:Neurofibromatosis type 1 (NF1) is a prevalent autosomal dominant disorder caused by mutations in the NF1 gene, leading to multisystem disorders. Given the critical role of cysteine residues in protein stability and function, we aimed to identify key NF1 mutations affecting cysteine residues that significantly contribute to neurofibromatosis pathology. To identify the most critical mutations in the NF1 gene that contribute to the pathology of neurofibromatosis, we employed a sophisticated computational pipeline specifically designed to detect significant mutations affecting the NF1 gene. Our approach involved an exhaustive search of databases such as the Human Gene Mutation Database (HGMD), UniProt, and ClinVar for information on missense mutations associated with NF1. Our search yielded a total of 204 unique cysteine missense mutations. We then employed in silico prediction tools, including PredictSNP, iStable, and Align GVGD, to assess the impact of these mutations. Among the mutations, C379R, R1000C, and C1016Y stood out due to their deleterious effects on the biophysical properties of the neurofibromin protein, significantly destabilizing its structure. These mutations were subjected to further phenotyping analysis using SNPeffect 4.0, which predicted disturbances in the protein's chaperone binding sites and overall structural stability. Furthermore, to directly visualize the impact of these mutations on protein structure, we utilized AlphaFold3 to simulate both the wild-type and mutant NF1 structures, revealing the significant effects of the R1000C mutation on the protein's conformation. In conclusion, the identification of these mutations can play a pivotal role in advancing the field of precision medicine and aid in the development of effective drugs for associated diseases.

Identification of a missense mutation causing exon skipping in a neurofibromatosis type 1 patient.

Case Report: A Synonymous Mutation in <i>NF1</i> Located at the Non-canonical Splicing Site Leading to Exon 45 Skipping

Genetic Analysis and Prenatal Diagnosis of a Sporadic Family with Neurofibromatosis Type 1

A Novel NF2 Mutation Associated with Neurofibromatosis Type 2 Causes Aberrant Splicing and Phase Separation

Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches

Rare NF1 Gene Mutation in Chinese Patient with Neurofibromatosis Type 1 and Anaplastic Astrocytoma.

Synonymous Variant at the Terminal Nucleotide in Exon 3 of F7 Causes Abnormal Splicing: A Case Report

Identification and analysis of gene mutations of an neurofibromatosis type 1 patient

Identification of a Germline CSPG4 Variation in a Family with Neurofibromatosis Type 1-Like Phenotype

Mutation analysis of the NF1 gene in two patients with neurofibromatosis type I

One novel mutation and copy number variation of NF1gene in Chinese patients with type 1 neurofibromatosis

Characterization of Two Loss-of-Function NF1 Variants in Chinese Patients and Potential Molecular Interpretations of Phenotypes.

Identification and characterization of a novel intronic splicing mutation in CSF1R‐related leukoencephalopathy

Mutation Analysis of NF2 Gene and Clinical Investigation in a Chinese Family with Neurofibromatosis Type II

Pathogenic Neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq

A novel NF1 frame-shift mutation (c.702_703delGT) in a Chinese family with neurofibromatosis type 1.

Novel Mutations in One Allele in a Chinese Family with Neurofibromatosis Type 1: Including a Complex Insertion–deletion Mutation

A Novel Mutation in NF1 Gene of Patient with Neurofibromatosis Type 1: A Case Report and Functional Study

Case Report: Identification Pathogenic Abnormal Splicing of BBS1 Causing Bardet–Biedl Syndrome Type I (BBS1) Due to Missense Mutation

[NF1 Mutation Analysis in a Chinese Family with Neuro- Fibromatosis Type].

Case Report: FOXP1 Syndrome Caused by a De Novo Splicing Variant (c.1652+5 G>A) of the FOXP1 Gene.